# A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day

> **NCT00952068** · PHASE2 · COMPLETED · sponsor: **Labopharm Inc.** · enrollment: 47 (actual)

## Conditions studied

- Acute Low Back Pain

## Interventions

- **DRUG:** Tramadol Contramid® OAD 200mg

## Key facts

- **NCT ID:** NCT00952068
- **Lead sponsor:** Labopharm Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952068, "A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00952068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*